Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Plant Genome ; 8(2): eplantgenome2014.09.0057, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-33228296

RESUMO

Natural antisense transcripts (NATs) are long noncoding RNAs (lncRNAs) complementary to the messenger (sense) RNA (Wang et al., 2014). Many of them are involved in regulation of their own sense transcripts thus playing pivotal biological roles in all processes of organismal development and responses to the environment. In our previous study, we have identified a number of differentially expressed genes (DEGs) in alfalfa plants (Medicago sativa L.) subjected to salinity stress (Postnikova et al., 2013). In this work, we selected several experimentally validated DEGs identified in response to salt and analyzed them for the presence of NAT pairs. The majority of the examined DEGs encoded NATs. Expression of some NAT pairs changed in response to salinity, suggesting their involvement in regulating the responses of alfalfa to salt.

2.
Curr Top Microbiol Immunol ; 332: 79-102, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19401822

RESUMO

Plant-derived biologicals for use in animal health are becoming an increasingly important target for research into alternative, improved methods for disease control. Although there are no commercial products on the market yet, the development and testing of oral, plant-based vaccines is now beyond the proof-of-principle stage. Vaccines, such as those developed for porcine transmissible gastroenteritis virus, have the potential to stimulate both mucosal and systemic, as well as, lactogenic immunity as has already been seen in target animal trials. Plants are a promising production system, but they must compete with existing vaccines and protein production platforms. In addition, regulatory hurdles will need to be overcome, and industry and public acceptance of the technology are important in establishing successful products.


Assuntos
Plantas Geneticamente Modificadas/genética , Plantas Geneticamente Modificadas/metabolismo , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/uso terapêutico , Vacinas de Subunidades Antigênicas/biossíntese , Vacinas de Subunidades Antigênicas/imunologia , Drogas Veterinárias/metabolismo , Drogas Veterinárias/uso terapêutico , Ensaios Clínicos como Assunto , Vírus da Gastroenterite Transmissível/genética , Vírus da Gastroenterite Transmissível/imunologia
3.
Arch Virol ; 151(7): 1373-86, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16489509

RESUMO

The Cucumber mosaic virus Ixora isolate (CMV) coat protein gene (CP) was placed under the transcriptional control of the duplicated subgenomic CP promoter of a Potato virus X (PVX)-based vector. In vitro RNA transcripts were inoculated onto Nicotiana benthamiana plants and recombinant CMV capsid proteins were identified on Western blots probed with CMV antibodies 5-7 days post-inoculation. PVX-produced CMV CP subunits were capable of assembling into virus-like particles (VLPs), which were visualized by electron microscopy. We further used the PVX/CMVCP system for transient expression of recombinant CMV CP constructs containing different neutralizing epitopes of Newcastle disease virus (NDV) engineered into the internal betaH-betaI (motif 5) loop. Both crude plant extracts and purified VLPs were immunoreactive with CMV antibodies as well as with epitope-specific antibodies to NDV, thus confirming the surface display of the engineered NDV epitope. Our study demonstrates the potential of PVX/CMVCP as an expression tool and as a presentation system for promising epitopes.


Assuntos
Proteínas do Capsídeo/biossíntese , Cucumovirus/imunologia , Epitopos/biossíntese , Expressão Gênica , Vetores Genéticos , Potexvirus/genética , Western Blotting , Proteínas do Capsídeo/genética , Proteínas do Capsídeo/imunologia , Cucumovirus/genética , Epitopos/genética , Microscopia Imunoeletrônica , Modelos Moleculares , Vírus da Doença de Newcastle/genética , Vírus da Doença de Newcastle/imunologia , RNA Viral/genética , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/genética , Recombinação Genética , Nicotiana/química , Nicotiana/genética , Virossomos/isolamento & purificação , Virossomos/ultraestrutura
4.
Arch Virol ; 149(6): 1201-14, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15168206

RESUMO

Beet mosaic virus (BtMV) was identified almost five decades ago but has not been fully characterized at the molecular level. In this study, we have determined for the first time the complete nucleotide sequence of BtMV genomic RNA and have developed a specific molecular means for its diagnosis. The viral genome of BtMV comprises 9591 nucleotides, excluding the 3' terminal poly (A) sequence, and contains a single open reading frame (ORF) that begins at nt 166 and terminates at nt 9423, encoding a single polyprotein of 3086 amino acid residues. A 3' untranslated region of 168 nucleotides follows the ORF. The deduced genome organization is typical for a member of the family Potyviridae and includes 10 proteins: P1, HC-Pro, P3, 6K1, CI, 6K2, NIa-VPg, NIa-Pro, NIb and coat protein (CP). Nine putative protease cleavage sites were predicted computationally and by analogy with genome arrangements of other potyviruses. Conserved sequence motifs of homologous proteins of other potyviruses were found in corresponding positions of BtMV. BtMV is a distinct species of the genus Potyvirus with the most closely related species being Peanut mottle virus ( approximately 55% amino acid identity). Based on the nucleotide sequence obtained, we have developed a virus-specific RT-PCR assay for accurate diagnosis and differentiation of BtMV.


Assuntos
Beta vulgaris/virologia , Genoma Viral , Doenças das Plantas/virologia , Poliproteínas/genética , Potyvirus/genética , Proteínas Virais/genética , Sequência de Aminoácidos , Sequência Consenso , Dados de Sequência Molecular , Potyvirus/isolamento & purificação , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Especificidade da Espécie
5.
Arch Virol ; 145(9): 1801-13, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-11043942

RESUMO

Extraction of viral double-stranded RNA from peach leaves infected with Apricot latent virus (ALV) followed by molecular cloning of synthesized cDNA and its sequencing, suggested that ALV is a new virus, whose coat protein (CP) coding region contains Apple stem pitting virus (ASPV)-related sequences. The sequenced portion of the ALV genome (1,444 nt) includes the putative CP gene and the 3' non-translated region. The 5' portion of this fragment (1-651 nt) is highly distinct whereas the 3' portion is 77% identical to the corresponding region of ASPV. Molecular hybridization experiments using a cRNA probe to ASPV with ALV-infected leaf tissue extracts also revealed that the genome of ALV contains nucleotide sequences related to that of ASPV. Western blots of tissue extracts indicated that ALV coat protein reacted with polyclonal antiserum against ASPV; however, the ALV CP differs in size from that of ASPV. ALV was graft-transmitted to several Prunus rootstocks. Based on the available sequence data, serological observations and bioassays we propose that ALV is a new species in the genus Foveavirus, typified by ASPV. ALV-specific PCR-primers and viral-specific cRNA probes developed in this investigation may be useful for detecting the virus and for studying its epidemiology and geographical distribution.


Assuntos
Capsídeo/genética , Genoma Viral , Vírus de Plantas/classificação , Rosales/virologia , Regiões 3' não Traduzidas/genética , Regiões 5' não Traduzidas/genética , Sequência de Aminoácidos , Sequência de Bases , Western Blotting , Capsídeo/química , Clonagem Molecular , Dados de Sequência Molecular , Hibridização de Ácido Nucleico , Filogenia , Vírus de Plantas/química , Vírus de Plantas/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Alinhamento de Sequência , Latência Viral
6.
Arch Virol ; 145(12): 2557-73, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-11205105

RESUMO

Hepatitis C virus (HCV) is a major cause of acute and chronic hepatitis with over 180 million cases worldwide. Vaccine development for HCV has been difficult. Presently, the virus cannot be grown in tissue culture and there is no vaccine or effective therapy against this virus. In this research, we describe the development of an experimental plant-derived subunit vaccine against HCV. A tobamoviral vector was engineered to encode a consensus sequence of hypervariable region 1 (HVR1), a potential neutralizing epitope of HCV, genetically fused to the C-terminal of the B subunit of cholera toxin (CTB). This epitope was selected from among the amino acid sequences of HVR1 "mimotopes" previously derived by phage display technology. The nucleotide sequence encoding this epitope was designed utilizing optimal plant codons. This mimotope is capable of inducing cross-neutralizing antibodies against different variants of the virus. Plants infected with recombinant tobacco mosaic virus (TMV) engineered to express the HVR1/CTB chimeric protein, contained intact TMV particles and produced the HVR1 consensus peptide fused to the functionally active, pentameric B subunit of cholera toxin. Plant-derived HVR1/CTB reacted with HVR1-specific monoclonal antibodies and immune sera from individuals infected with virus from four of the major genotypes of HCV. Intranasal immunization of mice with a crude plant extract containing the recombinant HVR1/CTB protein elicited both anti-CTB serum antibody and anti-HVR1 serum antibody which specifically bound to HCV virus-like particles. Using plant-virus transient expression to produce this unique chimeric antigen will facilitate the development and production of an experimental HCV vaccine. A plant-derived recombinant HCV vaccine can potentially reduce expenses normally associated with production and delivery of conventional vaccines.


Assuntos
Hepacivirus/genética , Proteínas de Plantas/biossíntese , Proteínas Recombinantes de Fusão/biossíntese , Vacinas contra Hepatite Viral/biossíntese , Administração Intranasal , Sequência de Aminoácidos , Animais , Sequência de Bases , Western Blotting , Toxina da Cólera/genética , Toxina da Cólera/imunologia , Ensaio de Imunoadsorção Enzimática , Epitopos/genética , Epitopos/imunologia , Feminino , Vetores Genéticos , Hepacivirus/imunologia , Hepatite C/prevenção & controle , Camundongos , Camundongos Endogâmicos C57BL , Dados de Sequência Molecular , Proteínas de Plantas/imunologia , Engenharia de Proteínas , Proteínas Recombinantes de Fusão/administração & dosagem , Proteínas Recombinantes de Fusão/imunologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Vírus do Mosaico do Tabaco/genética , Vacinação , Vacinas de Subunidades Antigênicas/biossíntese , Vacinas de Subunidades Antigênicas/imunologia , Vacinas contra Hepatite Viral/administração & dosagem , Vacinas contra Hepatite Viral/imunologia , Proteínas Virais/genética , Proteínas Virais/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA